AstraZeneca and CRT to develop cancer metabolism targeted therapies
08 February 2010

Cancer Research Technology (CRT) will collaborate with AstraZeneca to create a slate of new anticancer therapies over the next three years. CRT, the commercial and development arm of Cancer Research...

Pharma could hide adverse drug reaction reports under EU plans, NGOs say
08 February 2010

Eight organisations representing consumers, health insurers, healthcare professionals and NGOs are worried that the European Commission's draft legislative proposals on pharmacovigilance could see...

Cartilage replacement company spun out from Cardiff University
08 February 2010

Fusion IP, a UK-based university technology commercialisation company, has created a new spin-out company, Progenteq, under its exclusive agreement with Cardiff University. Progenteq is at the early...

Venus launches infused combination GI product in India
08 February 2010

Venus Remedies of India has launched on the domestic market a combination of the fluoroquinolone antibiotic ofloxacin and the nitroimidazole antiprotozoal compound ornidazole in infusion form, as...

Ranbaxy's US facility gets FDA warning letter
08 February 2010

The US FDA 's recent warning letter to Ohm Laboratories over good manufacturing practice (GMP) deviations at its plant in Gloversville, New York, includes concerns over certain postmarketing and...

US FDA prepares for biosimilars in 2011 budget plan, despite stalled reform bill
08 February 2010

As part of the unveiling of the Obama administration's fiscal year 2011 budget, FDA officials outlined how the agency plans to prepare for an approval pathway for follow-on biologics (or...

Interview: Rexbio sets sights on novel approach to pancreatic cancer
08 February 2010

The South Korean bioventure Rexbio is looking to develop a novel approach to the treatment and diagnosis of one of the most deadly forms of cancer by targeting a gene found to be closely linked to...

Alliance Pharma to buy Cambridge Laboratories' assets
08 February 2010

Alliance Pharma of the UK has agreed to buy the majority of the remaining assets of privately held Cambridge Laboratories for between £14.3 million and £16.4 million plus the value of inventory held...

Ex-BMS employee in US charged with trade-secret theft of SOPs
08 February 2010

US federal authorities have said that an ex-employee of Bristol-Myers Squibb in upstate New York has been arrested and charged with stealing trade secrets and proprietary information (including 1,327...

Novavax and Rovi end vaccine agreement
08 February 2010

Novavax has ended negotiations with Rovi Pharmaceuticals in pursuit of a collaboration to develop Novavax's virus-like-particle (VLP)-based vaccines against influenza in Spain. The split was blamed...

Roche/Ipsen push taspoglutide filing back to 2011
08 February 2010

Roche / Ipsen have announced that they will file the GLP-1 analogue taspoglutide for type 2 diabetes in 2011, back from previous expectations that it would be filed in the fourth quarter of this...

Kirin and Suntory call off merger talks
08 February 2010

Kirin and Suntory have decided to call off discussions aimed at a merger of the two companies, citing a number of irreconcilable differences over fundamental issues. The talks began last year and...

Roche sales boosted by Tamiflu but Genentech manoeuvre hits profits – update
05 February 2010

Roche has reported an 8% rise in 2009 sales to CHF49.1 billion ($46.6 billion), driven by sales of its influenza treatment Tamiflu (oseltamivir), its cancer portfolio and the age-related macular...

Israel's Supreme Court asks Sun to hold Taro warrant plan
05 February 2010

The Supreme Court of Israel has held that India's Sun Pharmaceutical Industries cannot go ahead with a warrant to purchase additional shares of Taro while a previous temporary injunction remains in...

Cellectricon sues Fluxion Biosciences for patent infringement
05 February 2010

The Swedish biotech company Cellectricon has resumed litigation against Fluxion Biosciences of the US, alleging infringement of its four US patents. It first filed the lawsuit in a district court in...